(VIANEWS) – Sotherly Hotels (SOHO), Rollins (ROL), Sapiens International Corporation N.V. (SPNS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Sotherly Hotels (SOHO)
14.4% sales growth and 20.21% return on equity
Sotherly Hotels Inc. is a self-managed and self-administered lodging REIT focused on the acquisition, renovation, upbranding and repositioning of upscale to upper-upscale full-service hotels in the Southern United States. Currently, the Company's portfolio consists of investments in twelve hotel properties, comprising 3,156 rooms, as well as interests in two condominium hotels and their associated rental programs. The Company owns hotels that operate under the Hilton Worldwide, Hyatt Hotels Corporation, and Marriott International, Inc. brands, as well as independent hotels. Sotherly Hotels Inc. was organized in 2004 and is headquartered in Williamsburg, Virginia.
Earnings Per Share
As for profitability, Sotherly Hotels has a trailing twelve months EPS of $0.08.
PE Ratio
Sotherly Hotels has a trailing twelve months price to earnings ratio of 18.13. Meaning, the purchaser of the share is investing $18.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.21%.
2. Rollins (ROL)
12.7% sales growth and 35.7% return on equity
Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, foodservice, and logistics. In addition, the company offers termite protection services and ancillary services. It serves clients directly, as well as through franchisee operations. Rollins, Inc. was incorporated in 1948 and is headquartered in Atlanta, Georgia.
Earnings Per Share
As for profitability, Rollins has a trailing twelve months EPS of $0.83.
PE Ratio
Rollins has a trailing twelve months price to earnings ratio of 52.11. Meaning, the purchaser of the share is investing $52.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.7%.
Yearly Top and Bottom Value
Rollins’s stock is valued at $43.25 at 05:22 EST, under its 52-week high of $45.04 and way above its 52-week low of $32.19.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Rollins’s EBITDA is 91.66.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 8, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 1.36%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.2%, now sitting on 2.98B for the twelve trailing months.
3. Sapiens International Corporation N.V. (SPNS)
9.2% sales growth and 14.84% return on equity
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines, as well as reinsurance and workers' compensation; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities. It also provides Sapiens DigitalSuite for insurance customers, agents, brokers, risk managers, customer groups and third-party service providers; Sapiens AgentConnect and Sapiens CustomerConnect portals; Sapiens Intelligence, an analytics platform; Sapiens IntelligencePro, a comprehensive BI solution with pre-configured reports, dashboards, and scorecards; and Sapiens Advanced Analytics, which uses AI and Machine Learning to generate actionable insights based on different models across the insurance value chain. In addition, the company offers Sapiens ReinsuranceMaster, Sapiens ReinsurancePro, and Sapiens Reinsurance GO reinsurance solutions; and Sapiens Platform, Sapiens CoreSuite, Sapiens PolicyPro, and Sapiens ClaimsPro, as well as Sapiens PolicyGo, Sapiens ClaimsGo, and Sapiens Connect for workers' compensation. Further, it provides financial and compliance solutions, which comprise Sapiens FinancialPro, Sapiens Financial GO, Sapiens StatementPro, Sapiens CheckPro, and Sapiens Reporting Tools; and Sapiens Decision, an enterprise-scale platform that enables institutions to centrally author, store, and manage various organizational business logics. Additionally, the company offers tailor-made solutions based on its Sapiens eMerge platform; and program delivery, business, and managed services. It markets and sells its products and services through direct and partner sales. The company was founded in 1982 and is headquartered in Holon, Israel.
Earnings Per Share
As for profitability, Sapiens International Corporation N.V. has a trailing twelve months EPS of $1.05.
PE Ratio
Sapiens International Corporation N.V. has a trailing twelve months price to earnings ratio of 25.93. Meaning, the purchaser of the share is investing $25.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.84%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 14, 2023, the estimated forward annual dividend rate is 0.51 and the estimated forward annual dividend yield is 1.87%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.8%, now sitting on 503.19M for the twelve trailing months.
Volume
Today’s last reported volume for Sapiens International Corporation N.V. is 43943 which is 64.83% below its average volume of 124974.
4. Vertex Pharmaceuticals (VRTX)
8.6% sales growth and 23.49% return on equity
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO and SYMDEKO/SYMKEVI for people with CF with at least one F508del mutation for 6 years of age or older; ORKAMBI for CF homozygous F508del mutation for CF patients 2 year or older; and KALYDECO for the treatment of patients with 4 months or older who have CF with a mutation that is responsive to ivacaftor, and R117H mutation or one of certain gating mutations. The company's pipeline includes VX-522, a CF mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial; and VX-864 for treatment of AAT deficiency, which is in Phase 2 clinical trial. In addition, it provides VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sell the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies or pharmacy chains, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Affinia Therapeutics; Arbor Biotechnologies, Inc.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Obsidian Therapeutics, Inc.; Verve Therapeutics; Skyhawk Therapeutics; and Ribometrix, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Vertex Pharmaceuticals has a trailing twelve months EPS of $13.34.
PE Ratio
Vertex Pharmaceuticals has a trailing twelve months price to earnings ratio of 32.59. Meaning, the purchaser of the share is investing $32.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.49%.
Yearly Top and Bottom Value
Vertex Pharmaceuticals’s stock is valued at $434.69 at 05:22 EST, below its 52-week high of $443.82 and way above its 52-week low of $283.60.
Moving Average
Vertex Pharmaceuticals’s worth is way above its 50-day moving average of $392.36 and way higher than its 200-day moving average of $359.81.
Sales Growth
Vertex Pharmaceuticals’s sales growth is 9.3% for the present quarter and 8.6% for the next.
Previous days news about Vertex Pharmaceuticals(VRTX)
- Vertex pharmaceuticals (vrtx) laps the stock market: here's why. According to Zacks on Monday, 29 January, "The upcoming earnings release of Vertex Pharmaceuticals will be of great interest to investors. ", "In the latest market close, Vertex Pharmaceuticals (VRTX Quick QuoteVRTX – Free Report) reached $435.82, with a +1.31% movement compared to the previous day. "
5. Marriott International (MAR)
7.4% sales growth and 1446.77% return on equity
Marriott International, Inc. operates, franchises, and licenses hotel, residential, timeshare, and other lodging properties worldwide. The company operates through U.S. and Canada, and International segments. It operates its properties under the JW Marriott, The Ritz-Carlton, Ritz-Carlton Reserve, W Hotels, The Luxury Collection, St. Regis, EDITION, Bvlgari, Renaissance, Le Méridien, Marriott, Sheraton, Westin, Four Points, Delta Hotels by Marriott, Autograph Collection, Tribute Portfolio, Marriott Hotels, Marriott Executive Apartments, Marriott Vacation Club, Gaylord Hotels, Design Hotels, Courtyard, Residence Inn, Fairfield, SpringHill Suites, TownePlace Suites, Protea Hotels, Aloft Hotels, AC Hotels by Marriott, Element Hotels, and Moxy Hotels brand names. It operates properties under 30 brand names in 138 countries and territories. Marriott International, Inc. was founded in 1927 and is headquartered in Bethesda, Maryland.
Earnings Per Share
As for profitability, Marriott International has a trailing twelve months EPS of $9.42.
PE Ratio
Marriott International has a trailing twelve months price to earnings ratio of 25.66. Meaning, the purchaser of the share is investing $25.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1446.77%.
Sales Growth
Marriott International’s sales growth is 4.8% for the current quarter and 7.4% for the next.
Volume
Today’s last reported volume for Marriott International is 912698 which is 38.46% below its average volume of 1483140.
6. JinkoSolar Holding Company Limited (JKS)
7.2% sales growth and 24.23% return on equity
JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in the design, development, production, and marketing of photovoltaic products. The company offers solar modules, silicon wafers, solar cells, recovered silicon materials, and silicon ingots. It also provides solar system integration services; and develops commercial solar power projects. The company sells its products to distributors, project developers, and system integrators; and utility, commercial, and residential customers under the JinkoSolar brand, as well as on an original equipment manufacturer basis. As of December 31, 2019, it had an integrated annual capacity of 15.0 gigawatt (GW) for silicon wafers, including 11.5 GW for mono wafers; 10.6 GW for solar cells; and 16.0 GW for solar modules. The company has operations in the People's Republic of China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, and internationally. JinkoSolar Holding Co., Ltd. was founded in 2006 and is based in Shangrao, the People's Republic of China.
Earnings Per Share
As for profitability, JinkoSolar Holding Company Limited has a trailing twelve months EPS of $10.24.
PE Ratio
JinkoSolar Holding Company Limited has a trailing twelve months price to earnings ratio of 2.86. Meaning, the purchaser of the share is investing $2.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.23%.
Volume
Today’s last reported volume for JinkoSolar Holding Company Limited is 340893 which is 68.43% below its average volume of 1079980.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 21, 2023, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 4.95%.
Moving Average
JinkoSolar Holding Company Limited’s value is way below its 50-day moving average of $32.99 and way under its 200-day moving average of $36.99.
Earnings Before Interest, Taxes, Depreciation, and Amortization
JinkoSolar Holding Company Limited’s EBITDA is 2.52.
7. Columbus McKinnon Corporation (CMCO)
5.8% sales growth and 6.23% return on equity
Columbus McKinnon Corporation designs, manufactures, and markets intelligent motion solutions to ergonomically move, lift, position, and secure materials worldwide. The company offers electric, air-powered, lever, and hand hoists; hoist trolleys, explosion-protected and custom engineered hoists, and winches; crane systems, such as crane components and kits, enclosed track rail systems, mobile and jib cranes, and fall protection systems, as well as material handling solutions; rigging equipment comprising below-the-hook lifting devices, shackles, chains and chains accessories, forestry and hand tools, lifting slings, lashing systems, and tie-downs and load binders; rotary unions and swivel joints; and mechanical and electromechanical actuators. It also provides power and motion technology products, including AC motor controls and line regenerative systems, automation and diagnostics, brakes, cable and festoon systems, collision avoidance systems, conductor bar systems, DC motor and magnet control systems, elevator drives, inverter duty motors, mining drives, pendant pushbutton stations, radio controls, and wind inverters; power delivery subsystems; overhead aluminum light rail workstations; and low profile, flexible chain, large scale, sanitary, and vertical elevation conveyor systems, as well as pallet system conveyors and accumulation systems. The company serves market verticals, including general industries, transportation, energy and utilities, process industries, industrial automation, construction and infrastructure, food and beverage, entertainment, life sciences, consumer packaged goods, and e-commerce/supply chain/warehousing. It offers its products to end users directly, as well as through distributors, independent crane builders, material handling specialists and integrators, government agencies, original equipment manufacturers, and engineering procurement and construction firms. The company was founded in 1875 and is headquartered in Buffalo, New York.
Earnings Per Share
As for profitability, Columbus McKinnon Corporation has a trailing twelve months EPS of $1.77.
PE Ratio
Columbus McKinnon Corporation has a trailing twelve months price to earnings ratio of 21.45. Meaning, the purchaser of the share is investing $21.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.23%.
Moving Average
Columbus McKinnon Corporation’s value is above its 50-day moving average of $36.97 and higher than its 200-day moving average of $36.82.
Volume
Today’s last reported volume for Columbus McKinnon Corporation is 14760 which is 87.95% below its average volume of 122516.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 978.11M for the twelve trailing months.
8. Charles Schwab (SCHW)
5.2% sales growth and 13.62% return on equity
The Charles Schwab Corporation, together with its subsidiaries, operates as a savings and loan holding company that provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. The company operates in two segments, Investor Services and Advisor Services. It offers brokerage accounts with equity and fixed income trading, margin lending, options trading, futures and forex trading, and cash management capabilities, including certificates of deposit; third-party mutual funds through the Mutual Fund Marketplace and Mutual Fund OneSource service, as well as mutual fund trading and clearing services to broker-dealers; exchange-traded funds; advisory solutions for managed portfolios, separately managed accounts, customized personal advice for tailored portfolios, specialized planning, and full-time portfolio management; banking products comprising checking and savings accounts, first lien residential real estate mortgage loans, home equity lines of credit, and pledged asset lines; and trust custody services, personal trust reporting services, and administrative trustee services. It also provides digital retirement calculators; integrated web-, mobile-, and software-based trading platforms, real-time market data, options trading, premium research, and multi-channel access; self-service education and support tools; online research and analysis tools; equity compensation plan sponsors full-service recordkeeping for stock plans, stock options, restricted stock, performance shares, and stock appreciation rights; and retirement plan services. The Company operates domestic branch offices in 48 states and the District of Columbia, as well as locations in Puerto Rico, the United Kingdom, Hong Kong, and Singapore. The Charles Schwab Corporation was founded in 1971 and is headquartered in Westlake, Texas.
Earnings Per Share
As for profitability, Charles Schwab has a trailing twelve months EPS of $2.54.
PE Ratio
Charles Schwab has a trailing twelve months price to earnings ratio of 25.02. Meaning, the purchaser of the share is investing $25.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.62%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 8, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1.57%.
Sales Growth
Charles Schwab’s sales growth is negative 7.2% for the ongoing quarter and 5.2% for the next.
Volume
Today’s last reported volume for Charles Schwab is 2721500 which is 72.86% below its average volume of 10030500.
